General Gynecology
RCT | In abortion surgery, Esketamine plus Propofol can reduce hypotension compared to Fentanyl plus Propofol.
14 Oct, 2022 | 13:58h | UTCCommentary: Esketamine as an adjunct with propofol and fentanyl to avoid perioperative hypotension – Physician’s Weekly
Systematic Review | Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency.
13 Oct, 2022 | 13:39h | UTCSummary: Which hormonal therapy works better for women with early failure of the ovaries? – Cochrane Library
Commentary on Twitter
What is the best combination of #hormones that would allow women to have a baby after they suffered from early failure of the ovaries?
Based on limited #evidence from 3 small studies, we were unable to draw any clear conclusions https://t.co/krgfRi9VT3@CochraneLibrary pic.twitter.com/o9dN96E2zP
— Cochrane Gynaecology & Fertility (@CochraneCGF) October 7, 2022
Guideline Summary | Diagnostic stewardship for urinary tract infection.
11 Oct, 2022 | 13:37h | UTCOriginal Guideline: Optimal Urine Culture Diagnostic Stewardship Practice—Results from an Expert Modified-Delphi Procedure – Clinical Infectious Diseases
Secondary prevention of cervical cancer | ASCO resource–stratified guideline update.
6 Oct, 2022 | 13:44h | UTC
Cohort Study | Predicting major complications in patients undergoing laparoscopic and open hysterectomy for benign indications.
6 Oct, 2022 | 13:42h | UTCNews Release: Easy-to-use tool predicts complications in patients undergoing hysterectomy for benign disease
Commentary: Models Predicting Complications of Hysterectomy Developed – HealthDay
Commentary on Twitter
Researchers have developed prediction tools to guide shared decision-making for people with benign conditions considering either laparoscopic or open abdominal hysterectomy: https://t.co/SVNeM4L85b@QMUL @TheBSGE #OBGYNtwitter pic.twitter.com/oHz1Po0eJB
— CMAJ (@CMAJ) October 4, 2022
RCT | Self-cut vs. Mesh-Kit titanium-coated polypropylene Mesh for transvaginal treatment of severe pelvic organ prolapse.
30 Sep, 2022 | 12:38h | UTCCommentary: Self-Cut Mesh Noninferior for Pelvic Organ Prolapse Procedure – HealthDay
Systematic Review | Impact of residual disease in women with advanced epithelial ovarian cancer after primary surgery.
30 Sep, 2022 | 12:28h | UTC
M-A | Carbon dioxide laser vs. vaginal estrogen for genitourinary syndrome of menopause.
29 Sep, 2022 | 13:24h | UTC
Commentary on Twitter
Vaginal laser and vaginal estrogen therapy showed similar improvement in genitourinary symptoms in this systematic review and meta-analysis of RCTs. #Research https://t.co/PpAf77CqKS
— JAMA Network Open (@JAMANetworkOpen) September 21, 2022
RCT | Immunogenicity and safety of one-dose human papillomavirus vaccine vs. two or three doses.
29 Sep, 2022 | 13:21h | UTCInvited Commentary: HPV vaccines: when one plus one equals three – The Lancet Global Health
Related:
RCT: Single-dose HPV vaccination found effective among young African women.
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
Opinion: A Single-dose HPV Vaccine Would Have a Big Impact on Cancer Prevention
Another Observational Study Suggests One Dose of HPV Vaccine may be Enough
Another Study Suggesting One Dose of HPV Vaccine may be Effective for Prevention of Cervical Cancer
Large Observational Study Suggests One Dose of HPV Vaccine May Be as Effective as Three
USPSTF Recommendation Statement | Screening for Syphilis infection in nonpregnant adolescents and adults.
28 Sep, 2022 | 13:52h | UTCEditorial:
Resurgence of Syphilis in the US—USPSTF Reaffirms Screening Guidelines – JAMA Dermatology
The Critical Need to Modernize Syphilis Screening – JAMA
Screening for Syphilis in Nonpregnant Adults and Adolescents – JAMA Network Open
JAMA Patient Page: Screening for Syphilis
Author Interview: USPSTF Recommendation: Syphilis Screening in Nonpregnant Adolescents and Adults
Commentary: USPSTF Recommends Syphilis Screening for At-Risk Persons – HealthDay
Validation of the geriatric vulnerability score in older patients with ovarian cancer.
27 Sep, 2022 | 13:00h | UTC
RCTs | Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids.
20 Sep, 2022 | 13:19h | UTC
Systematic Review | Debulking hysterectomy followed by chemoradiotherapy vs. chemoradiotherapy alone for women with locally advanced cancer of the cervix – not enough evidence to guide recommendations.
19 Sep, 2022 | 12:39h | UTC
Review | Obesity and contraceptive use: impact on cardiovascular risk.
16 Sep, 2022 | 12:53h | UTCObesity and contraceptive use: impact on cardiovascular risk – ESC Heart Failure
News Release: Combined birth control pill linked with increased risk of blood clots in obese women – European Society of Cardiology
M-A | Role of pessaries in the treatment of pelvic organ prolapse.
15 Sep, 2022 | 13:08h | UTCRole of Pessaries in the Treatment of Pelvic Organ Prolapse: A Systematic Review and Meta-analysis – Obstetrics & Gynecology (free for a limited period)
Systematic Review | Ultra‐radical (extensive) surgery vs. standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
13 Sep, 2022 | 12:56h | UTCRelated Study: Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer – New England Journal of Medicine
Survey | Medical counseling on sexual enrichment aids: women’s preferences and medical practitioner expertise.
11 Sep, 2022 | 22:42h | UTC
Screening for high-risk human papillomavirus using passive, self-collected menstrual blood.
11 Sep, 2022 | 22:41h | UTCCommentary: Pap smears, be gone? Using menstrual blood to detect HPV – Stanford Medicine
Commentary on Twitter
FREE: Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood #obgyn #HPV #GYN https://t.co/zLno2ab605 pic.twitter.com/mfPGjlTLdD
— The Green Journal (@greenjrnl) September 1, 2022
Systematic Review | Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use.
2 Sep, 2022 | 13:07h | UTC
RCT | Placement of an intrauterine device within 48 hours after early medical abortion.
1 Sep, 2022 | 11:51h | UTC
A simple cervicovaginal epigenetic test for screening and rapid triage of women with suspected endometrial cancer: validation in several cohort and case/control sets.
29 Aug, 2022 | 11:58h | UTC
Commentary on Twitter
Pleased to share our work out today in J Clin Oncol "A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer …" #FORECEE #CCBIO #H2020 @eveappeal @Gynkreft @medofak_uib @haukeland_no
#screening https://t.co/Av53WSWqoQ pic.twitter.com/dL4j7nW7vt— Line Bjørge (@DrLB) August 24, 2022
Under a https://creativecommons.org/licenses/by/4.0/ license
RCT | HPV self-sampling among long-term non-attenders to cervical cancer screening.
26 Aug, 2022 | 13:27h | UTC
Commentary on Twitter
Pragmatic randomised controlled trial of 3 different HPV screening approaches suggests that opt-in and particularlly send-to-all self-sampling increased participation among long-term, higher-risk non-attenders: https://t.co/hBouqoBMnU #GynCSM #hsronc
— NatureRevClinOncol (@NatRevClinOncol) August 25, 2022
Endocervical sampling in women with suspected cervical neoplasia: a systematic review and meta-analysis of diagnostic test accuracy studies.
26 Aug, 2022 | 13:18h | UTC
Systematic Review | Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
26 Aug, 2022 | 13:11h | UTC
A review of more than 2000 cases of site-specific pelvic endometriosis rates by MRI: a guide to minimizing under/overdiagnosis non-invasively.
26 Aug, 2022 | 13:08h | UTC